Related Experiment Video
Updated: Feb 11, 2026

Blastomere Explants to Test for Cell Fate Commitment During Embryonic Development
Published on: January 26, 2013
Global H3.3 dynamic deposition defines its bimodal role in cell fate transition
Hai-Tong Fang1, Chadi A El Farran1,2, Qiao Rui Xing1,3
1Epigenetics and Cell Fates Laboratory, Programme in Stem Cell, Regenerative Medicine and Ageing, A*STAR Institute of Molecular and Cell Biology, Singapore, 138673, Singapore.
Abstract:
H3.3 is a histone variant, which is deposited on genebodies and regulatory elements, by Hira, marking active transcription. Moreover, H3.3 is deposited on heterochromatin by Atrx/Daxx complex. The exact role of H3.3 in cell fate transition remains elusive. Here, we investigate the dynamic changes in the deposition of the histone variant H3.3 during cellular reprogramming. H3.3 maintains the identities of the parental cells during reprogramming as its removal at early time-point enhances the efficiency of the process. We find that H3.3 plays a similar role in transdifferentiation to hematopoietic progenitors and neuronal differentiation from embryonic stem cells. Contrastingly, H3.3 deposition on genes associated with the newly reprogrammed lineage is essential as its depletion at the later phase abolishes the process. Mechanistically, H3.3 deposition by Hira, and its K4 and K36 modifications are central to the role of H3.3 in cell fate conversion. Finally, H3.3 safeguards fibroblast lineage by regulating Mapk cascade and collagen synthesis.
Related Concept Videos
Phase Transitions: Sublimation and Deposition
Role of Microtubules in Cell Wall Deposition
Phase Transitions
Global Climate Change
Phase Transitions: Vaporization and Condensation
Properties of Transition Metals

